**Trader consensus at 90% for "No" reflects the absence of any novel pathogen showing sustained global human-to-human transmission as of mid-June 2026.** CDC data show COVID-19 infections declining in most U.S. states with low emergency department and hospitalization rates, while seasonal respiratory viruses wind down. Regional Ebola (Bundibugyo virus) activity in the DRC and Uganda remains under WHO monitoring but shows no evidence of efficient international spread. Measles cases have risen in the U.S. due to vaccination gaps, yet this involves a known, vaccine-preventable pathogen rather than a new pandemic threat. Surveillance from agencies like the CDC and WHO continues to track zoonotic risks such as avian influenza and "Disease X" candidates, but model consensus and current observational data indicate low near-term escalation probability before year-end. New data releases or model updates from these bodies could shift sentiment if transmissibility indicators rise unexpectedly.